Combined administration of antibiotics increases the incidence of antibiotic-associated diarrhea in critically ill patients

References

• Bartlett JG. Antibiotic associated diarrhea. N Engl J Med. 2002;346(5):334–339. doi:10.1056/NEJMcp01160311821511
   PubMed Web of Science ®Google Scholar
• Tian CF, Su BY, Li YJ, et al. Management of antibiotic-associated pseudomembranous colitis in Non-hospitalized and hospitalized patients. Pak J Pharm Sci. 2016;29(5(Suppl)):1805–1810.28476706
   PubMed Web of Science ®Google Scholar
• Huang H, Wu S, Wang M, et al. Molecular and clinical characteristics of clostridium difficile infection in an university hospital in Shanghai, China. Clin Infect Dis. 2008;47(12):1606−1608. doi:10.1086/59632119025371
   PubMed Web of Science ®Google Scholar
• Surawicz CM, Brandt LJ, Binion DG, et al. Guidelines for diagnosis,treatment,and prevention of clostridium difficile infections. Am J Gastroenterol. 2013;108(4):478–498. doi:10.1038/ajg.2013.423439232
   PubMed Web of Science ®Google Scholar
• Plummer S, Weaver MA, Harris JC, Dee P, Hunter J. Clostridium difficile pilot study: effectsof probiotic supplementation on the incidence of C.difficile diarrhoea. Int Microbiol. 2004;7:59–62.15179608
   PubMed Web of Science ®Google Scholar
• Schroeder MS. Clostridium difficile-associated diarrhea. Am Fam Physician. 2005;71:921–928.15768622
   PubMed Web of Science ®Google Scholar
• Giannelli FR. Antibiotic-associated diarrhea. JAAPA. 2017;30(10):46–47. doi:10.1097/01.JAA.0000524721.01579.c9
   Google Scholar
• Blaabjerg S, Artzi DM, Aabenhus R. Probiotics for the prevention of antibiotic-associated diarrhea in outpatients-a systematic review and meta-analysis. Antibiotics. 2017;6(4):21–37. doi:10.3390/antibiotics6040021
   Web of Science ®Google Scholar
• Shen NT, Maw A, Tmanova LL, et al. Timely use of probiotics in hospitalized adults prevents clostridium difficile infection: a systematic review with meta-regression analysis. Gastroenterology. 2017;152(8):1889–1900. doi:10.1053/j.gastro.2017.02.00328192108
   PubMed Web of Science ®Google Scholar
• Kelly CP. A 76-year-old man with recurrent clostridium difficile-associated diarrhea: review of Clostridium difficile infection. JAMA. 2009;301:954–962. doi:10.1001/jama.2009.17119190304
   PubMed Web of Science ®Google Scholar
• Mejia-Chew C, Dubberke ER. Clostridium difficile control measures: currentand future methods for prevention. Expert Rev Anti Infect Ther. 2018;16(2):121–131. doi:10.1080/14787210.2018.142991129353504
   PubMed Web of Science ®Google Scholar
• Hempel S, Newberry SJ, Maher AR, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: asystematic review and meta-analysis. JAMA. 2012;307(18):1959–1969. doi:10.1001/jama.2012.350722570464
   PubMed Web of Science ®Google Scholar
• Ruiter-Ligeti J, Vincent S, Czuzoj-Shulman N, Abenhaim HA. Risk factors, incidence, and morbidity associated with obstetric clostridium difficile infection. Obstet Gynecol. 2018;131(2):387–391. doi:10.1097/AOG.000000000000242229324599
   PubMed Web of Science ®Google Scholar
• Oughton MT, Miller MA. Clinical and epidemiological aspects of Clostridium diffcile. Clin Microbiol Newsl. 2008;30(12):87–95. doi:10.1016/j.clinmicnews.2008.05.004
   Google Scholar
• Videlock EJ, Cremonini F. Meta-analysis: probioticsin antibiotic-associated diarrhea. Aliment Pharmacol Ther. 2012;35(12):1355–1369. doi:10.1111/j.1365-2036.2012.05104.x22531096
   PubMed Web of Science ®Google Scholar
• Vernice MFL, Metehan O, Cagri DE, et al. Comparison of pediatric and adult antibiotic-associated diarrhea and\r, Clostridium difficile\r, infections. World J Gastroenterol. 2016;22(11):3078–3104. doi:10.3748/wjg.v22.i11.307827003987
   PubMed Web of Science ®Google Scholar
• Khanna S, Pardi DS, Aronson SL, et al. The epidemiology of community-acquired clostridium difficile infection: a population-based study. Am J Gastroenterol. 2012;107(1):89–95. doi:10.1038/ajg.2011.39822108454
   PubMed Web of Science ®Google Scholar
• Debast SB, Bauer MP, Kuijper EJ. European society of clinical microbiology and infectious diseases: update of the treatment guidance document for clostridium difficile infection. Clin Microbiol Infec. 2014;20(s2):1–26. doi:10.1111/1469-0691.12418
   Web of Science ®Google Scholar
• Lau CS, Chamberlain RS. Probiotics are effective at preventing clostridium difficile-associated diarrhea: asystematic review and meta-analysis. Int J Gen Med. 2016;9:27–37. doi:10.2147/IJGM.S9828026955289
   PubMed Web of Science ®Google Scholar
• Yoldas O, Altindis M, Cufali D, Aşık G, Keşli R. A diagnostic algorithm for the detection of clostridium difficile-associated diarrhea. Balkan Med J. 2016;33(1):80–86. doi:10.5152/balkanmedj.2015.1515926966622
   PubMed Web of Science ®Google Scholar
• Roberts T, Kokaikun JF, Coughlin O, et al. Tolerability and pharmacokinetics of SYN-004,an orally administered β-lactamase for the prevention of clostridium difficile-associated disease and antibiotic-associated diarrhea,in two phase 1 studies. Clin Drug Investig. 2016;36(9):725–734. doi:10.1007/s40261-016-0420-0
   PubMed Web of Science ®Google Scholar
• Viswanathan VK, Mallozzi MJ, Vedantam G. Clostridium difficile infection: anoverview of the disease and its pathogenesis,epidemiology and interventions. Gut Microbes. 2010;1(4):234–242. doi:10.4161/gmic.1.4.1270621327030
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sun J, Zhang J, Liu Y, Guo L. Beta-lactam plus enzyme inhibitor antibiotics and antibiotic-associated diarrhea in critically Ill patients. Med Sci Monit. 2018;24:8781–8788. doi:10.12659/MSM.91373930512009
   PubMed Web of Science ®Google Scholar
• Owens RC, Donskey CJ, Gaynes RP, Loo VG, Muto CA. Antimicrobial-associated risk factors for clostridium difficile infection. Clin Infect Dis. 2008;46(1):S19–S31. doi:10.1086/52185918177218
   PubMed Web of Science ®Google Scholar
• Bauer MP, van Dissel JT. Alternative strategies for clostridium difficile infection. Int J Antimicrob Agents. 2009;33(1):S51–S56. doi:10.1016/S0924-8579(09)70018-419303571
   PubMed Web of Science ®Google Scholar
• Rotramel A, Poritz LS, Messaris E, Berg A, Stewart DB. PPI therapy and albumin are better predictors of recurrent clostridium difficile colitis than choice of antibiotics. Gastrointest Surg. 2012;16:2267–2273. doi:10.1007/s11605-012-2037-9
   Web of Science ®Google Scholar
• Howell MD, Novack V, Grgurich P, et al. Iatrogenic gastric acid suppression and the risk of nosocomial clostridium difficile infection. Arch Intern Med. 2010;170(9):784–790. doi:10.1001/archinternmed.2010.8920458086
   PubMedGoogle Scholar